Noninvasive prenatal diagnosis: Pregnant women's interest and expected uptake

Prenatal Diagnosis

Volumn 31, Issue 13, 2011, Pages 1292-1299

  Tischler, Reana ^a   Hudgins, Louanne ^a   Blumenfeld, Yair J ^a   Greely, Henry T ^a,b,c   Ormond, Kelly E ^a,c  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD LAW SCHOOL   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Noninvasive prenatal diagnosis; Patient decision making; Prenatal screening, chromosome abnormalities; Prenatal testing

Indexed keywords

ADULT; AMBIVALENCE; ARTICLE; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; FETUS; GENETIC COUNSELING; HEALTH CARE PERSONNEL; HUMAN; NON INVASIVE PROCEDURE; NONINVASIVE PRENATAL DIAGNOSIS; PATIENT DECISION MAKING; PHYSICIAN; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT;

ABORTION, INDUCED; ADULT; AGE FACTORS; CHROMOSOME DISORDERS; FEMALE; GENETIC TESTING; HUMANS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; PRENATAL DIAGNOSIS; QUESTIONNAIRES; SAFETY; SOCIOECONOMIC FACTORS;

EID: 82255192286     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2888     Document Type: Article

References (42)

1. American College of Obstetrics and Gynecology Practice Bulletin No. 88, December 2007.Invasive prenatal testing for aneuploidy. Obstet Gynecol 110(6): 1459-1467.
2. Benn PA, Chapman AR. 2009. Practical and Ethical Considerations of Noninvasive Prenatal Diagnosis. JAMA 301(20): 2154-2156.
3. Benn PA, Chapman AR. 2010. Ethical challenges in providing noninvasive prenatal diagnosis. Curr Opin Obstet Gynecol 22: 128-134.
4. Bishop AJ, Marteau TM, Armstrong D, et al. 2004. Women and health care professionals' preferences for Down's syndrome screening tests: a conjoint analysis. BJOG 111: 775-779.
5. California Department of Public Health. 2009. Prenatal Diagnosis Center Manual. [18 April 2011].
6. Center for Disease Control and Prevention, National Vital Statistics System. 2008 Birth Data-Characteristics of Mother. [31 March 2011].
7. Chiu RWK, Akolekar R, Zheng YWL, et al. 2011. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 342: c7401.
8. De Jong A, Dondorp WJ, de Die-Smulders CEM, et al. 2010. Non-invasive prenatal testing: ethical issues explored. Eur J Hum Genet 18: 272-277.
9. Deans Z, Newson A. 2010. Should Non-Invasiveness Change Informed Consent Procedures for Prenatal Diagnosis? Health Care Anal. DOI 10.1007/s10728-010-0146-8 [Epub ahead of print].
10. Ehrich M, Deciu C, Zwiefelhofer, T, et al. 2011. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol, 204: 205.e1-e11.
11. Evans MI, Kilpatrick M. 2010. Noninvasive Prenatal Diagnosis: 2010. Clin Lab Med 30: 655-665.
12. Fan HK, Quake SR. 2010. Sensitivity of Noninvasive Prenatal Detection of Fetal Aneuploidy from Maternal Plasma Using Shotgun Sequencing Is Limited Only by Counting Statistics. PLoS One 5(5): e10439.
13. Fan HK, Blumenfeld YJ, Chitkara U, et al. 2008. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. PNAS 105(42): 16266-16271.
14. Gene Security Network. 2011. Non-invasive Prenatal Diagnosis [Online], Available at: [June 1, 2011].
15. Greely HT. 2011. Get ready for the flood of fetal gene screening. Nature 469: 289-291.
16. Hall A, Bostanci A, Wright CF. 2010. Non-Invasive Prenatal Diagnosis Using Cell-Free Fetal DNA Technology: Applications and Implications. Public Health Genomics 13: 246-255.
17. Herzenberg LA, Bianchi DW, Schroeder J, et al. 1979. Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting. Proc Natl Acad Sci 76: 1453-1455.
18. Kelly SE, Farrimond HR. 2011. Non-invasive prenatal diagnosis: A study of public attitudes. Public Health Genomics, in press.
19. Kobleka C, Mattman A, Langlois S. 2009. An evaluation of the decision-making process regarding amniocentesis following a screen-positive maternal serum screen result. Prenat Diagn 29: 514-519.
20. Kooj L, Tymstra T, van den Verg P. 2009. The attitudes of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA. Prenat Diagn 29: 164-168.
21. Kuppermann M, Gates E, Washington A. 1996. Racial-ethnic differences in prenatal diagnostic test use and outcomes: Preferences, socioeconomics, or patient knowledge. Obstet Gynecol 87: 675-682.
22. Learman LA, Kuppermann M, Gates E, et al. 2003. Social and familial context of prenatal genetic testing decisions: Are there racial/ethnic differences? Am J Med Genet 119C(1): 19-26.
23. Lo YMD, Corbetta N, Chamberlain PF. 1997. Presence of fetal DNA in maternal plasma and serum. Lancet 360: 485-487.
24. Lumley MA, Zamerowski SA, Jackson L, et al. 2006. Psychosocial correlates of pregnant women's attitudes toward prenatal maternal serum screening and invasive diagnostic testing: Beyond traditional risk status. Genet Test 10(2): 131-138.
25. Mueller VM, Huang T, Summers AM, Winsor SHM. 2005. The influence of risk estimates obtained from maternal serum screening on amniocentesis rates. Prenat Diagn 25: 1253-1257.
26. Nakata N, Wang Y, Bhatt S. 2010. Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age. Prenat Diagn 30: 198-206.
27. Newson AJ. 2008. Ethical aspects arising from non-invasive fetal diagnosis. Semin Fetal Neonatal Med 13: 103-108.
28. Poon LLM, Leung TN, Lau TK, Lo YM. 2000. Presence of fetal RNA in maternal plasma. Clin Chem 46: 1832-1824.
29. Saucier JB, Johnston D, Wicklund CA, et al. 2005. Racial-ethnic differences in genetic amniocentesis uptake. J Genet Counseling 14(3): 189-195.
30. Schmitz D, Henn W, Netzer C. 2009. No risk, no objections? Ethical pitfalls of cell-free fetal DNA and RNA testing. BMJ 339: 165.
31. Sequenom Inc. 2011. Professor Dennis Lo Trisomy 21 Clinical Validation Study Published in British Medical Journal [Online], Available at: home/media/news/ [June 1, 2011].
32. Seror V, Ville Y. 2009. Prenatal screening for Down syndrome: women's involvement in decision-making and their attitudes to screening. Prenat Diagn 29: 120-128.
33. Skotko BG. 2009. With new prenatal testing, will babies with Down syndrome slowly disappear? Arch Dis Child 94(11): 823-826.
34. Spencer K, Aitken D. 2004. Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies. Ultrasound Obstet Gynecol 24: 735-739.
35. Teman E, Ivry T, Bernhardt B. 2010. Pregnancy as a Proclamation of Faith: Ultra-Orthodox Jewish Women Navigating the Uncertainty of Pregnancy and Prenatal Diagnosis. Am J Med Genet, Part A 155: 69-80.
36. Van de Heuvel A, Chitty L, Dormandy E, et al. 2009. Will the Introduction of Non-Invasive Prenatal Diagnostic Testing Erode Informed Choices? An Experimental Study of Health Care Professionals. Patient Educ Couns 78: 24-28.
37. Van den Berg M, Timmermans DRM, ten Kate LP, et al. 2005. Are pregnant women making informed choices about prenatal screening? Genet Med 7(5): 332-338.
38. Van Landingham S, Bienstock J, Wood Denne E, Hueppchen N. 2011. Beyond first trimester screen: Can we predict who will choose invasive testing? Genet Med. DOI: 10.1097/GIM.0b013e31820a7701 [Epub ahead of print].
39. Verinata Health. 2011. Maternal and Fetal Health [Online], Available at: [June 1, 2011].
40. White M. 2009. Making Sense of Genetic Uncertainty: The Role of Religion and Spirituality. Am J Med Genet, 151C: 68-76.
41. Wright CF, Chitty LS. 2009. Cell-Free Fetal DNA and RNA in Maternal Blood: Implications for Safer Antenatal Testing. BMJ 339: 161-165.
42. Zamerowski ST, Lumley MA, Arreola RA, et al. 2001. Favorable attitudes toward testing for chromosomal abnormalities via analysis of fetal cells in maternal blood. Genet Med 3(4): 301-309.